Currently, the influence of brusatol on the Nrf2 pathway in pancreatic cancer cells remains unclear, whereas the influence of brusatol on ROS expression in various cancer cells remains controversial. This evidence concerns the gene NFE2L2 and familial pancreatic carcinoma.